BiotechTube

Drospirenone/17ß-estradiol (Angeliq, BAY86-4891) + Drospirenone/17ß-estradiol (Angeliq, BAY86-4891) + SH K 00641 C - Medroxyprogesterone acetate / conjugated equine (Prempro TM)

Phase 2Completed
0 watching 0 views this week⚡ Active
49
Hype Score

Development Stage

✓
Pre-clinical
✓
Phase 1
3
Phase 2
4
Phase 3
5
Approved
Indication / Disease

Postmenopause

Conditions

Postmenopause, Hypertension, Pre-Hypertension

Trial Timeline

Jan 1, 2007 → Sep 1, 2008

NCT ID
NCT00420342

About Drospirenone/17ß-estradiol (Angeliq, BAY86-4891) + Drospirenone/17ß-estradiol (Angeliq, BAY86-4891) + SH K 00641 C - Medroxyprogesterone acetate / conjugated equine (Prempro TM)

Drospirenone/17ß-estradiol (Angeliq, BAY86-4891) + Drospirenone/17ß-estradiol (Angeliq, BAY86-4891) + SH K 00641 C - Medroxyprogesterone acetate / conjugated equine (Prempro TM) is a phase 2 stage product being developed by Bayer for Postmenopause. The current trial status is completed. This product is registered under clinical trial identifier NCT00420342. Target conditions include Postmenopause, Hypertension, Pre-Hypertension.

Hype Score Breakdown

Clinical
17
Activity
12
Company
7
Novelty
5
Community
5

Clinical Trials (1)

NCT IDPhaseStatus
NCT00420342Phase 2Completed

Competing Products

16 competing products in Postmenopause

See all competitors
ProductCompanyStageHype Score
Comparator: placebo + Comparator: EstraceMerckPhase 1
33
bazedoxifene/conjugated estrogens combination tabletPfizerPhase 1
32
Bazedoxifene 10 mg/CE 0.625 mg + Bazedoxifene 20 mg/CE 0.625 mg + Bazedoxifene 40 mg/CE 0.625 mg + Bazedoxifene 10 mg/CE 0.45 mg + Bazedoxifene 20 mg/CE 0.45 mg + Bazedoxifene 40 mg/CE 0.45 mg + Raloxifene 60 mg + PlaceboPfizerPre-clinical
22
PremarinPfizerPre-clinical
22
Bazedoxifene and conjugated estrogensPfizerPhase 1
32
Premarin/MPA + Premarin/MPA + Provera 10 mgPfizerPhase 1
32
Bazedoxifene/conjugated estrogensPfizerPhase 1
32
PremarinPfizerPhase 1
32
bazedoxifene BZA-20PfizerPhase 3
76
Trimegestone + 17b EstradiolPfizerApproved
84
Premarin/MPA 0.45 mg/1.5 mgPfizerPhase 1
32
Conjugated Estrogen Cream (Premarin®)PfizerPre-clinical
22
Estradiol/DRSP (Angeliq, BAY86-4891)BayerApproved
82
0.25mg DRSP / 0.5mg E2 (BAY86-4891) + 0.5mg NETA / 1.0mg E2 (Activella)BayerPhase 3
74
E2/LNG oral (Wellnara, BAY86-5029)BayerPre-clinical
20
Tibolone + Estradiol + Estradiol + Medroxy Progesterone AcetateOrganonApproved
80

Other Products from Bayer

TelmisartanApproved
82
Clotrimazole vaginal tablet + FluconazoleApproved
82
Levitra (Vardenafil, BAY38-9456)Approved
82
Avelox (Moxifloxacin, BAY12-8039) + Amoxicillin clavulanic acidApproved
82
Rivaroxaban 20 MG + WarfarinApproved
82